Alpha 2.0
Login Register
» Articles » PMID: 28368254

Stereotactic Body Radiotherapy for Patients with Hepatocellular Carcinoma and Intermediate Grade Cirrhosis

Overview
Journal Lancet Oncol
Specialty Oncology
Date 2017 Apr 4
PMID 28368254
Citations 4
Authors
Nima Nabavizadeh
Timur Mitin
Laura A Dawson
Theodore S Hong
Charles R Thomas Jr
Affiliations
Soon will be listed here.
Citing Articles

Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma.

Omar A, Kaseb A, Elbaz T, El-Kassas M, El Fouly A, Hanno A J Hepatocell Carcinoma. 2023; 10:1547-1571.

PMID: 37744303 PMC: 10516190. DOI: 10.2147/JHC.S404424.

Interleukin-6-Production Is Responsible for Induction of Hepatic Synthesis of Several Chemokines as Acute-Phase Mediators in Two Animal Models: Possible Significance for Interpretation of Laboratory Changes in Severely Ill Patients.

Malik I, Ramadori G Biology (Basel). 2022; 11(3).

PMID: 35336843 PMC: 8945369. DOI: 10.3390/biology11030470.

High rate of complete histopathological response in hepatocellular carcinoma patients after combined transarterial chemoembolization and stereotactic body radiation therapy.

Bauer U, Gerum S, Roeder F, Munch S, Combs S, Philipp A World J Gastroenterol. 2021; 27(24):3630-3642.

PMID: 34239274 PMC: 8240047. DOI: 10.3748/wjg.v27.i24.3630.

PECAM-1 modulates liver damage induced by synergistic effects of TNF-α and irradiation.

Malik G, Wilting J, Hess C, Ramadori G, Malik I J Cell Mol Med. 2019; 23(5):3336-3344.

PMID: 30761739 PMC: 6484309. DOI: 10.1111/jcmm.14224.